Nanospectra Biosciences Email Format

Biotechnology ResearchUnited States2-10 Employees

Nanospectra Biosciences is a United States–based biotechnology research company focused on developing medical device technologies for selective thermal ablation, a treatment approach that targets diseased tissue while aiming to spare surrounding healthy tissue. Its work centers on nanomedicine applications within oncology, with a market positioned among peers pursuing targeted therapies and thermal ablation methods for cancer treatment. The company serves medical and research customers seeking innovative approaches to minimally invasive cancer care, addressing the need for precise, localized therapy. Based in Houston, Texas, Nanospectra has progressed through multiple rounds of financing and notable leadership additions in its recent history, reflecting ongoing development in its therapeutic platform. A recent development involves strategic collaboration with Sirtex Medical, including board participation and potential access to AuroLase therapy in non-U.S. regions, signaling broader interest in its technology within the field.

Sign up for free to view info

Company overview Employee directory